197 related articles for article (PubMed ID: 37007745)
1. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma.
Liu T; Chen Z; Chen W; Evans R; Xu J; Reeves ME; de Vera ME; Wang C
Precis Clin Med; 2023 Mar; 6(1):pbad004. PubMed ID: 37007745
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
3. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
4. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis.
Byeon S; du Toit-Thompson T; Gillson J; Gill AJ; Samra JS; Mittal A; Sahni S
Cancer Med; 2023 Sep; 12(17):18020-18031. PubMed ID: 37537839
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.
Truong LH; Pauklin S
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638513
[TBL] [Abstract][Full Text] [Related]
8. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer.
Sempere LF; Powell K; Rana J; Brock AA; Schmittgen TD
Cancer Metastasis Rev; 2021 Sep; 40(3):761-776. PubMed ID: 34591242
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma.
Zhang X; Lan R; Liu Y; Pillarisetty VG; Li D; Zhao CL; Sarkar SA; Liu W; Hanna I; Gupta M; Hajdu C; Melamed J; Shusterman M; Widmer J; Allendorf J; Liu YZ
Res Sq; 2024 May; ():. PubMed ID: 38798691
[TBL] [Abstract][Full Text] [Related]
13. Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma.
Tang R; Zhang Z; Xu J; Wang W; Meng Q; Liu Y; Du Q; Liang C; Hua J; Zhang B; Yu X; Shi S
Comput Struct Biotechnol J; 2024 Dec; 23():1689-1704. PubMed ID: 38689717
[TBL] [Abstract][Full Text] [Related]
14. Single cell RNA-seq analysis with a systems biology approach to recognize important differentially expressed genes in pancreatic ductal adenocarcinoma compared to adjacent non-cancerous samples by targeting pancreatic endothelial cells.
Jamali E; Safarzadeh A; Hussen BM; Liehr T; Ghafouri-Fard S; Taheri M
Pathol Res Pract; 2023 Aug; 248():154614. PubMed ID: 37329816
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma.
Ye B; Wang Q; Zhu X; Zeng L; Luo H; Xiong Y; Li Q; Zhu Q; Zhao S; Chen T; Xie J
Front Oncol; 2023; 13():1236435. PubMed ID: 37601684
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.
Maneshi P; Mason J; Dongre M; Öhlund D
Front Cell Dev Biol; 2021; 9():787485. PubMed ID: 34901028
[TBL] [Abstract][Full Text] [Related]
17. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
Front Oncol; 2020; 10():621937. PubMed ID: 33520728
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets.
Chen K; Liu X; Liu W; Wang F; Tian X; Yang Y
Hum Mol Genet; 2022 May; 31(10):1705-1719. PubMed ID: 34957503
[TBL] [Abstract][Full Text] [Related]
19. Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.
Olaoba OT; Yang M; Adelusi TI; Maidens T; Kimchi ET; Staveley-O'Carroll KF; Li G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672552
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy.
Chen K; Ma Y; Liu X; Zhong X; Long D; Tian X; Zheng L; Yang Y
Cancer Lett; 2023 Nov; 576():216421. PubMed ID: 37778681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
